| scholarly article | Q13442814 |
| P50 | author | Satyakam Singh | Q42858875 |
| P2093 | author name string | Xiao-Dong Su | |
| Fang Wang | |||
| Zhe-Sheng Chen | |||
| Suresh V Ambudkar | |||
| Tanaji T Talele | |||
| Hai-Ying Wu | |||
| Ke-Jun Liu | |||
| Xing-Gui Chen | |||
| Li-Wu Fu | |||
| Jie-Hua He | |||
| Hong-May Sim | |||
| Jing-Dun Xie | |||
| Kamlesh Sodani | |||
| Yong-Ju Liang | |||
| P2860 | cites work | Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein | Q40390330 |
| Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. | Q40530013 | ||
| Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. | Q40561425 | ||
| Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 | Q41130127 | ||
| Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression | Q42814970 | ||
| Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors | Q42921884 | ||
| Combined pharmacophore modeling, docking, and 3D QSAR studies of ABCB1 and ABCC1 transporter inhibitors | Q43273710 | ||
| Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein | Q44543802 | ||
| Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance | Q44687014 | ||
| Screening novel, potent multidrug-resistant modulators from imidazole derivatives | Q45011364 | ||
| Computational models for identifying potential P-glycoprotein substrates and inhibitors | Q48547412 | ||
| Quantitative structure-activity relationship of multidrug resistance reversal agents | Q73626792 | ||
| Effect of BIBF 1120 on reversal of ABCB1-mediated multidrug resistance | Q83360720 | ||
| LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling | Q24296238 | ||
| Src family kinases in tumor progression and metastasis | Q24311656 | ||
| Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line | Q24338329 | ||
| Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters | Q24617999 | ||
| Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding | Q24657908 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| The human ATP-binding cassette (ABC) transporter superfamily | Q28204495 | ||
| The role of ABC transporters in drug resistance, metabolism and toxicity | Q28283237 | ||
| Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function | Q28475378 | ||
| Cellular functions regulated by Src family kinases | Q29616038 | ||
| Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Q33194199 | ||
| Characterization of a side population of cancer cells from human gastrointestinal system | Q33225639 | ||
| Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells | Q33399904 | ||
| Structural, mechanistic and clinical aspects of MRP1. | Q33784449 | ||
| Src in cancer: deregulation and consequences for cell behaviour | Q33959239 | ||
| P-glycoprotein: from genomics to mechanism. | Q34272173 | ||
| Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). | Q34743441 | ||
| Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. | Q34803651 | ||
| Identifying and characterizing binding sites and assessing druggability | Q34980548 | ||
| Activation of the PI3K/Akt pathway and chemotherapeutic resistance | Q35046899 | ||
| Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein | Q35076190 | ||
| A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study | Q35576853 | ||
| Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system | Q36610461 | ||
| Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). | Q36995781 | ||
| Mutational analysis of ABC proteins | Q37104958 | ||
| Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 | Q37119716 | ||
| Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). | Q37818370 | ||
| Pharmacology of drugs that alter multidrug resistance in cancer | Q37969138 | ||
| Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells | Q38333889 | ||
| Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells | Q38337454 | ||
| ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance | Q38510908 | ||
| Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. | Q39881351 | ||
| Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol | Q40036920 | ||
| Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance | Q40050525 | ||
| Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo | Q40345597 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | saracatinib | Q21098957 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 224-235 | |
| P577 | publication date | 2012-06-13 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo | |
| P478 | volume | 132 |
| Q28541630 | A new 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) derivative overcomes paclitaxel resistance by inhibiting MAPK signaling and increasing paclitaxel accumulation in breast cancer cells |
| Q36413392 | Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. |
| Q41471408 | Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer |
| Q33654580 | Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid |
| Q58572040 | Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells |
| Q36335981 | Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2. |
| Q38810143 | Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells |
| Q39152151 | PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells |
| Q36182381 | Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis |
| Q49347037 | Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy |
| Q30679405 | Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer |
| Q47214772 | The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer. |
| Q49888021 | Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells. |
| Q36702964 | Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo |
Search more.